Literature DB >> 9013568

Hemopoietic growth factors with the exception of interleukin-4 activate the p38 mitogen-activated protein kinase pathway.

I N Foltz1, J C Lee, P R Young, J W Schrader.   

Abstract

The mammalian mitogen-activated protein (MAP) kinase homologue p38 has been shown to be activated by pro-inflammatory cytokines as well as physical and chemical stresses. We now show that a variety of hemopoietic growth factors, including Steel locus factor, colony stimulating factor-1, granulocyte/macrophage-colony stimulating factor, and interleukin-3, activate p38 MAP kinase and the downstream kinase MAPKAP kinase-2. Furthermore, although these growth factors activate both p38 MAP kinase and Erk MAP kinases, we demonstrate using a specific inhibitor of p38 MAP kinase, SB 203580, that p38 MAP kinase activity was required for MAP kinase-activated protein kinase-2 activation. Conversely p38 MAP kinase was shown not to be required for in vivo activation of p90(rsk), known to be downstream of the Erk MAP kinases. Interleukin-4 was unique among the hemopoietic growth factors we examined in failing to induce activation of either p38 MAP kinase or MAP kinase-activated protein kinase-2. These findings demonstrate that the activation of p38 MAP kinase is involved not only in responses to stresses but also in signaling by growth factors that regulate the normal development and function of cells of the immune system.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9013568     DOI: 10.1074/jbc.272.6.3296

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Protein kinase C-delta regulates thrombin-induced ICAM-1 gene expression in endothelial cells via activation of p38 mitogen-activated protein kinase.

Authors:  A Rahman; K N Anwar; S Uddin; N Xu; R D Ye; L C Platanias; A B Malik
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

Review 2.  Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets.

Authors:  D W Hommes; M P Peppelenbosch; S J H van Deventer
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

3.  Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway.

Authors:  M Rincón; H Enslen; J Raingeaud; M Recht; T Zapton; M S Su; L A Penix; R J Davis; R A Flavell
Journal:  EMBO J       Date:  1998-05-15       Impact factor: 11.598

4.  Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures.

Authors:  N R Bhat; P Zhang; J C Lee; E L Hogan
Journal:  J Neurosci       Date:  1998-03-01       Impact factor: 6.167

5.  Inhibition of p38 MAPK reduces expression of vascular endothelial growth factor in allergic airway disease.

Authors:  So Ri Kim; Kyung Sun Lee; Seoung Ju Park; Myung Shin Jeon; Yong Chul Lee
Journal:  J Clin Immunol       Date:  2012-02-24       Impact factor: 8.317

6.  Heat-shock protein-25/27 phosphorylation by the delta isoform of protein kinase C.

Authors:  E T Maizels; C A Peters; M Kline; R E Cutler; M Shanmugam; M Hunzicker-Dunn
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

7.  PRAK, a novel protein kinase regulated by the p38 MAP kinase.

Authors:  L New; Y Jiang; M Zhao; K Liu; W Zhu; L J Flood; Y Kato; G C Parry; J Han
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

8.  Contribution of the p38MAPK signalling pathway to proliferation in human cultured airway smooth muscle cells is mitogen-specific.

Authors:  Darren J Fernandes; Claire E Ravenhall; Trudi Harris; Thai Tran; Ross Vlahos; Alastair G Stewart
Journal:  Br J Pharmacol       Date:  2004-07-12       Impact factor: 8.739

9.  P38 mitogen activated protein kinase expression and regulation by interleukin-4 in human B cell non-Hodgkin lymphomas.

Authors:  Hu Ding; Ali M Gabali; Stephen D Jenson; Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  J Hematop       Date:  2009-10-21       Impact factor: 0.196

10.  Dual specificity phosphatase 1 regulates human inducible nitric oxide synthase expression by p38 MAP kinase.

Authors:  Tuija Turpeinen; Riina Nieminen; Ville Taimi; Taina Heittola; Outi Sareila; Andrew R Clark; Eeva Moilanen; Riku Korhonen
Journal:  Mediators Inflamm       Date:  2011-04-19       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.